期刊文献+

肝硬化上消化道出血患者经奥美拉唑联合奥曲肽治疗的临床研究 被引量:17

Clinical Study on Patients With Omeprazole Combined With Octreotide in the Treatment of Cirrhosis With Upper Gastrointestinal Bleeding
下载PDF
导出
摘要 目的 对肝硬化上消化道出血患者经奥美拉唑联合奥曲肽治疗进行临床研究。方法 选取我院2010年10月-2015年10月收治的肝硬化上消化道出血患者128例,随机分为对照组和观察组,对照组使用奥美拉唑进行治疗,观察组使用奥美拉唑联合奥曲肽治疗,对比分析两组患者止血时间和治疗效果。结果 观察组止血时间和治疗效果均优于对照组,差异具有统计学意义(P〈0.05),观察组治疗总有效率为96.88%,对照组治疗总有效率为65.62%。结论 奥美拉唑联合奥曲肽能够有效治疗肝硬化上消化道出血患者。 Objective For patients treated by omeprazole combined with octreotide in clinical study of cirrhosis with upper gastrointestinal bleeding. Methods Liver cirrhosis were selected in our hospital from October 2010 to October 2015, 128 patients of hemorrhage of upper digestive tract, and randomly assigned to control group and the observation group, the control group used omeprazole treatment, the observation group used omeprazole combined with octreotide in the treatment of, comparative analysis of two groups of patients stop bleeding time and treatment effect. Results Observation group hemostasis time and treatment effect were better than the control group, the difference was statistically significant (P〈0.05), the total effective rate of observation group was 96.88%, and the control group was 65.62%. Conclusion Omeprazole combined with octreotide can effectively treat patients with gastrointestinal bleeding in liver cirrhosis digestive.
作者 李进
出处 《中国继续医学教育》 2016年第20期125-126,共2页 China Continuing Medical Education
关键词 肝硬化上消化道出血 奥美拉唑 奥曲肽 Liver cirrhosis and upper digestive tract bleeding,Omeprazole, Octreotide
  • 相关文献

二级参考文献44

  • 1叶任高.内科学[M]5版[M].北京:人民卫生出版社,2000.961.
  • 2Nikoda V V, Bondarenko A V, Kiriushin D N, et al. Pre- vention of stress- induced damage of the upper gastrointesti- nal mucosa in patients during early postoperative period[J ]. Anesteziol Reanimatol, 2012(2) : 51.
  • 3Suk K T, Kim H S, Lee C S, et al. Clinical outcomes and risk factors of rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage [ J , Clin En- dosc, 2011, 44(2): 93.
  • 4Rattanasupar A. Role of clinical parameters for predicting the cause of upper gastrointestinal bleeding [ J ]. J Med Assoc Thai, 2012, 95(1): 22.
  • 5Melinte- Popescu M, Blan G. The role of upper gastroin- testinal endoscopy in evaluation of portal hypertension [ J ]. Rev Med Chir Soc Med Nat Iasi, 2011, 115(4) : 1003.
  • 6Savi Z, Vracari V, Hadnadjev L, et al. Experience in the treatment of some complications of portal hypertension in al- coholic liver cirrhosis[J 1. Vojnosanit Pregl, 2011, 68 ( 11 ) : 917.
  • 7Gonzdlez E J, Rivera - Acosta J E, Sdnchez J M, et al. Management of upper gastrointestinal bleeding in cirrhotic pa- tients with documented esophageal varices evaluated at the Puerto Rico Medical Center[J]. Bol Asoc Med P R, 2011, 103(1): 5.
  • 8ANd S, Jafri W, Harnid S, et al. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with en- doscopic band ligation: a randomized double- blind placebo- controlled trial J ]. Am J Gastroenterol, 2009, 104 ( 3 ) : 617.
  • 9Heidelbaugh J J, Sherbondy M. Cirrhosis and chronic liver failure: part II. Complications and treatment[J]. Am Faro Physician, 2006, 74(5): 767.
  • 10D'Amico G, De Franchis R, Cooperative Study Group. Up- per digestive bleeding in cirrhosis. Post - therapeutic outcome and prognostic indicators [ J ]. Hepatology, 2003, 38 ( 3 ) : 599.

同被引文献74

引证文献17

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部